Report

BVXV: Positive Results in NIH-Sponsored Phase 2 Trial of M-001; Raising Valuation to $81...

Underlying
BIONDVAX PHARMACEUTICALS

Provider
Zacks
Zacks

​Zacks Investment Research is a Chicago based firm with over 30 years of experience in providing institutional and individual investors with the analytical tools and financial information necessary to the success of their investment process.

Other Reports on these Companies
Other Reports from Zacks

ResearchPool Subscriptions

Get the most out of your insights

Get in touch